Tutti i video
Type 2 diabetes: access to treatment of vascular complications
it
Prof. Angelo Avogaro
Autoantibody screening for prevention of type 1 diabetes
it
Prof. Emanuele Bosi
Why use CGMs in type 2 diabetes also
en
Prof. Satish Garg
Una "App" per facilitare la prevenzione pre-diabete e le nuove cure
it
Prof. Paolo Fiorina
ATTD: time in range recommendations by the Consensus Group
en
Prof. Tadej Battelino
Diabete: con i nuovi farmaci, costi minori per le complicanze
it
Prof. Giulio Marchesini R.
Il monitoraggio continuo è la coscienza elettronica del diabetico
it
Prof. Albino Bottazzo
Tissue Engineering and Cellular Replacement in Diabetes Treatment
en
Prof. Camillo Ricordi
Children with endocrine disorders
it
Dott. Marco Cappa
Nutrition and lifestyle, the key to preventing type 2 diabetes
it
Prof. Riccardo Candido
How to prevent or delay the onset of type 2 diabetes from prediabetes
en
Prof. Satish Garg
Role and function of the ATTD yearbook
en
Prof. Moshe Phillip
Il ruolo del paziente-tutor nella diffusione dell'uso dei nuovi device
it
Fabiana Anastasio
Ingegneria tissutale e ricambio cellulare nel trattamento del diabete
it
Prof. Camillo Ricordi
Effective self-monitoring of glycaemia: why this procedure is indispensable
it
Prof. Salvatore Caputo
The resistance to change in diabetes management
en
Prof. Satish Garg
Type 2 Diabetes: One in Three Patients Still Undiagnosed
it
Stefano Nervo
A balanced view on microbiome in obesity
en
Prof. Max Nieuwdorp
Continuità d'intervento tra la fase pre-diabete e quella del diabete
it
Prof. Paolo Fiorina
The role of adjunctive therapies for people with type 1 diabetes
en
Prof. Satish Garg
Con i sistemi di controllo continuo non invasivo migliora l'aderenza alla terapia
it
Lina Delle Monache
Is Type 1 Diabetes Mellitus an Autoimmune Disease?
en
Prof. Mark Sperling
Efficacy of treatments and quality of life
it
Dott. Marco Cappa
The hot topics discussed at ATTD 2023
en
Prof. Satish Garg
The Evolution of Glycemic Targets: Time in Tight Range
en
Prof. Viral N. Shah
SGLT in T1D: "STICH Protocol" for mitigating risk of ketoacidosis
en
Dr. Thomas Danne
Bambini diabetici: ottenere prescrivibilità Free Style Libre
it
Patrizia Pappini
Big data open a new era in diabetes management
en
Dr. Thomas Danne
How does the new method work. Cost-benefit ratio
it
Prof. Emanuele Bosi
Will new pharmacological treatment for obesity and early diabetes replace bariatric surgery?
en
Prof. Luca Busetto
I nuovi farmaci antidiabetici nei percorsi di cura: costi e benefici
it
Dr. Paolo Di Bartolo
New insulins, biosimilars, and insulin therapy
en
Prof. Lutz Heinemann
Le terapie sperimentali allo studio per l'insufficienza renale
it
Prof. Paolo Fiorina
Determining glycaemic variability: the role of AGP
it
Dott. Stefano Genovese
L'impegno sul territorio degli ambulatori Fatebenefratelli-Sacco
it
Prof. Paolo Fiorina
The importance of the titration period for basal insulin initiation
en
Dr. Robert A. Ritzel
Diabete gestazionale: conseguenze sul feto e nel corso della vita
it
Prof. Giorgio Mello
Clinical case: Claudio Pellizzeni’s AGP analyses
it
Dott. Stefano Genovese
Predictive insulin suspension prevents hypoglycemia
en
Dr. Pratik Choudhary
Is the gut the "sweet spot" for the treatment of type 2 diabetes?
en
Prof. Francesco Rubino
Diabete T2: trend epidemiologico e impatto complicanze
it
Prof. Paolo Fiorina
E' l'intestino il punto più adatto per il trattamento del diabete di tipo 2?
it
Prof. Francesco Rubino
Glucose monitoring: from the glucose meter to the Free St. Libre system
it
Prof. Salvatore Caputo
Reimbursement policies for Continuous Glucose Monitoring
en
Prof. Lutz Heinemann
Type 1 diabetes variabilities are easier to manage with AGP
it
Prof. Emanuele Bosi
New mealtime insulins: pharmacokinetic and pharmacodynamic data
en
Prof Christophe De Block
Continuous, non-invasive blood glucose measurement
en
Prof. Emanuele Bosi
Patient compliance and application range of the new system
it
Dott. Stefano Genovese
Diabetes technologies need doctor and patient structured education
it
Prof. Olga Kordonouri
I vantaggi della misurazione glicemica continua e non invasiva
en
Prof. Emanuele Bosi
New devices for T1D: the experience at the Schneider Institute
en
Dr. Nimri Revital
Impact of exercise on glucose control in type 1 diabetes
en
Prof. Marc Breton
Bambino diabetico: distress mitigato da efficacia dei nuovi device
it
Dr. Vincenzo Provenzano
Remotely managing CGM technology with smartphones
en
Prof. Timothy Bailey
The practical use of retrospective CGM
en
Dr. Michael Joubert
Good results from patients trained with the bolus calculator
en
Prof. Kirsten Nørgaard
CGM: opportunities from new technologies
en
Dr. Luigi Laviola
CGM: quali opportunità dalle nuove tecnologie
it
Dr. Luigi Laviola
Glicemia del liquido interstiziale: vantaggi per i bambini diabetici
it
Dr. Dario Iafusco
Freestyle Libre is a major advance in avoiding ipoglicemia
it
Dr. Gerry Rayman
The benefits of Professional Continous Glucose Monitoring
en
Dr. Robert Vigersky
A study based on the device Abbott Libre Flash Glucose Monitor
en
Dr. Helen McCullagh
Designing an ecosystem of diabetes applications
en
Howard Look
Type 1 management: traditional pump vs device PAC by Secure
en
Lucia Novak
Preventing stroke and dementhia. The new targets
en
Prof. Dagmara Hering